NuCana (NCNA) EPS (Weighted Average and Diluted) (2021 - 2024)

NuCana's (NCNA) quarterly EPS (Weighted Average and Diluted) came in at $0.15 in Q2 2024, up 21.04% year-on-year from $0.13 in Q3 2023, and up 21.04% quarter-over-quarter from $0.13 in Q2 2023.

NuCana (NCNA) EPS (Weighted Average and Diluted) (2021 - 2024) Analysis & Trends

NuCana has disclosed EPS (Weighted Average and Diluted) across 4 years of filings, most recently posting $0.15 for Q2 2024.

  • EPS (Weighted Average and Diluted) for Q2 2024 came in at $0.15, up 21.04% year-over-year; the trailing twelve-month figure through Jun 2023 was -$144.91 (down 583.81% YoY), and the FY2024 annual result was -$0.33, up 49.58% from the prior year.
  • EPS (Weighted Average and Diluted) came in at $0.15 for Q2 2024 at NuCana, up from $0.13 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.15 in Q2 2024 to a low of -$29.64 in Q2 2021.
  • The 4-year median for EPS (Weighted Average and Diluted) is -$10.53 (2022), against an average of -$12.64.
  • Across the five-year window, EPS (Weighted Average and Diluted) soared 100.59% in 2023 and climbed 21.04% in 2024, its largest moves.
  • NuCana's EPS (Weighted Average and Diluted) stood at -$29.64 in 2021, then grew by 28.51% to -$21.19 in 2022, then jumped by 100.59% to $0.13 in 2023, then gained by 21.04% to $0.15 in 2024.
  • The last three EPS (Weighted Average and Diluted) figures came in at $0.15 (Q2 2024), $0.13 (Q2 2023), and -$21.19 (Q2 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 0.68
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 3.06
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 3,086.42
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 0.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 0.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 4.02
9 Abivax 94.26 Bn 94.26 Bn - -0.61
10 NuCana 29.13 Bn 29.13 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 0.15
Jun 30, 2023 0.13
Jun 30, 2022 -21.19
Jun 30, 2021 -29.64